Invictus (TSXV:GENE, OTC:IVITF) is pleased to report that the Company’s Chief Evangelist Officer Gene Simmons is taking Invictus with him on the KISS End of the Road Tour. The rock legend and media mogul, recently hosted backstage meetings with Invictus stakeholders along with Invictus President and Chief Executive Officer George Kveton and members of the Board prior to and following the band’s March 22 appearance at Scotiabank Arena.
As Chief Evangelist Officer of Invictus, Mr. Simmons is planning to meet with the Company’s constituents, partners and stakeholders on tour stops around the world.
“I am devoted to Invictus and my other business partners, and the tour provides me with an opportunity to put them on an international stage,” said Mr. Simmons. “I work around the clock no matter where I am in the world.”
In addition to taking Invictus on tour, Mr. Simmons will continue to represent the Company at key business and investor conferences in North America. Past appearances have included speaking roles at MJBiz in New Orleans and at Money Show conferences in Las Vegas, San Francisco and Toronto among others. As a popular and prolific guest on notable business and news media programming, Mr. Simmons will also continue to represent Invictus in the media.
For more information, please visit www.invictus-md.com.
On Behalf of the Board,
George E. Kveton
Chief Executive Officer and Director
Vice President, Public Relations and Regulatory Affairs
Invictus is a global cannabis company offering a selection of products under a wide range of brands. Our integrated sales approach is defined by five pillars of distribution including medical, adult-use, international, Licensed Producer to Licensed Producer and retail stores.
Invictus has partnered with business leaders to convey our corporate vision, including KISS music legend and business mogul Gene Simmons as our Chief Evangelist Officer. To meet growing demand, Invictus is expanding its cultivation footprint, with three cannabis production facilities licensed under the Cannabis Act and Cannabis Regulations in Canada. To accommodate international sales, Invictus’ wholly-owned subsidiary, Acreage Pharms Ltd. (“Acreage Pharms”), has designed and is currently building its Phase 3 purpose-built cultivation facility to be European Union Good Manufacturing Practices (“EU-GMP”) compliant. The Company is targeting up to 50 percent of production to medical cannabis. To ensure consistency in quality and supply, Invictus maintains all aspects of the growing process through its subsidiary, Future Harvest Development Ltd. (“Future Harvest”), a high-quality fertilizer and nutrients manufacturer. Invictus drives sustainable long-term shareholder value through a diversified product portfolio with over 70 Health Canada approved strains and a multifaceted distribution strategy including medical, adult-use, international, Licensed Producer to Licensed Producer and retail stores. For more information visit www.invictus-md.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.